These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39002515)

  • 1. Aromatase inhibitors for the treatment of breast cancer: An overview (2019-2023).
    Bhatia N; Thareja S
    Bioorg Chem; 2024 Oct; 151():107607. PubMed ID: 39002515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch.
    Ratre P; Mishra K; Dubey A; Vyas A; Jain A; Thareja S
    Anticancer Agents Med Chem; 2020; 20(17):1994-2004. PubMed ID: 32593281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
    Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
    Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
    Adhikari N; Baidya SK; Jha T
    Eur J Med Chem; 2020 Dec; 208():112845. PubMed ID: 33017749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
    Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
    Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
    Muftuoglu Y; Mustata G
    Bioorg Med Chem Lett; 2010 May; 20(10):3050-64. PubMed ID: 20413308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase: the enzyme and its inhibition.
    Banting L; Ahmed S
    Anticancer Agents Med Chem; 2009 Jul; 9(6):627-41. PubMed ID: 19601746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in study of the structure, catalytic mechanism and inhibitors of aromatase].
    Fu J; Shen ZH; Cheng FX; Liu GX; Li WH; Tang Y
    Yao Xue Xue Bao; 2012 Jan; 47(1):18-28. PubMed ID: 22493800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
    Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
    BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview.
    Ratre P; Kulkarni S; Das S; Liang C; Mishra PK; Thareja S
    Med Oncol; 2022 Dec; 40(1):41. PubMed ID: 36471176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors: Role in postmenopausal breast cancer.
    Kharb R; Haider K; Neha K; Yar MS
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000081. PubMed ID: 32449548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
    Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overview.
    Bhatia N; Hazra S; Thareja S
    Eur J Med Chem; 2023 Aug; 256():115422. PubMed ID: 37163948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
    Jiao J; Xiang H; Liao Q
    Curr Med Chem; 2010; 17(30):3476-87. PubMed ID: 20738251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study.
    Adhikari N; Amin SA; Saha A; Jha T
    Eur J Med Chem; 2017 Sep; 137():365-438. PubMed ID: 28622580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.
    Stauffer F; Furet P; Floersheimer A; Lang M
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1860-3. PubMed ID: 22335894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
    Banjare L
    Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal aromatase inhibitors for the treatment of breast cancer: an update.
    Gobbi S; Rampa A; Belluti F; Bisi A
    Anticancer Agents Med Chem; 2014 Jan; 14(1):54-65. PubMed ID: 23869785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
    Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.